11 results
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... Summary Table ... Sulfonylureas GLP ... SGLT2 inhibitors ... #medications #table
Effects on body weight of various classes of type-2 diabetes medications.
 - Metformin - Weight Loss
weight of various classes ... of type-2 diabetes ... medications ... Loss + - SGLT-2 inhibitors ... Weight Loss ++ - GLP
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Type 2 Inpatient Medication ... Guide Classes ... , GLP-1 receptor ... α-glucosidase inhibitor ... pharmacology #comparison #table
Hypomagnesemia - Etiologies by Mechanism

Decreased GI Uptake 
 - Poor dietary intake (particularly common in alcoholics)
Renal Loses - Medications ... - Uncontrolled diabetes ... Low #Magnesium #Table ... #Classification ... #Causes #Workup
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
DPP-4 Inhibitors ... Mechanisms of Action: Inhibits ... Januvia) - Once/day tablet ... not definitively cause ... #Summary #DM2 #diabetes
Shock - Differential Diagnosis by Classification
Reflex Syncope 
 - Vasovagal syncope
   • Prolonged standing
Differential Diagnosis by Classification ... depletion - Medication ... disease • Diabetes ... Alcohol blackout - Medication ... #Table #Causes
Diuretics and Agents Regulating Renal Excretion

Carbonic Anhydrase Inhibitors (Acetazolamide, Dichlorphenamide)
 • Glaucoma
 • Epilepsy
 • Altitude
• Nephrogenic diabetes ... Kidney stones caused ... DDAVP) • Central diabetes ... #Pharmacology #Medications ... #Table
Causes of Unintentional Weight Loss - Differential Diagnosis
Malignancy 
 - Tumor effect* (esp. Gl, lung, lymphoma)
Causes of Unintentional ... : Uncontrolled diabetes ... pulmonary cachexia") Medications ... , SGLT2 inhibitors ... , GLP-I agonists
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
) - First Oral GLP ... semaglutide, the same medication ... Rybelsus will be dispensed ... drug to remain stable ... #semaglutide #Diabetes
Hyperkalemia - Diagnosis and Management - GrepMed Handbook

S/Sx: Most pts asymptomatic. Weakness, cramping, nausea, paresthesias, palpitations,
Etiology: • Medications ... infusion, Calcineurin inhibitors ... only if no clear cause ... Elimination (see Table ... NOT hypertonic Amp